- Home
- RNXT vs DRIO Comparison
RNXT vs DRIO Comparison
Compare RNXT & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- DRIO
- Stock Information
- Founded
- RNXT 2012
- DRIO 2011
- Country
- RNXT United States
- DRIO United States
- Employees
- RNXT N/A
- DRIO N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- RNXT Health Care
- DRIO Health Care
- Exchange
- RNXT Nasdaq
- DRIO Nasdaq
- Market Cap
- RNXT 37.6M
- DRIO 23.9M
- IPO Year
- RNXT 2021
- DRIO N/A
- Fundamental
- Price
- RNXT $1.06
- DRIO $0.76
- Analyst Decision
- RNXT Strong Buy
- DRIO Strong Buy
- Analyst Count
- RNXT 2
- DRIO 1
- Target Price
- RNXT $7.00
- DRIO $2.00
- AVG Volume (30 Days)
- RNXT 117.4K
- DRIO 233.5K
- Earning Date
- RNXT 05-15-2025
- DRIO 05-14-2025
- Dividend Yield
- RNXT N/A
- DRIO N/A
- EPS Growth
- RNXT N/A
- DRIO N/A
- EPS
- RNXT N/A
- DRIO N/A
- Revenue
- RNXT $43,000.00
- DRIO $27,040,000.00
- Revenue This Year
- RNXT $4,755.81
- DRIO $22.41
- Revenue Next Year
- RNXT $187.93
- DRIO $19.97
- P/E Ratio
- RNXT N/A
- DRIO N/A
- Revenue Growth
- RNXT N/A
- DRIO 32.86
- 52 Week Low
- RNXT $0.75
- DRIO $0.50
- 52 Week High
- RNXT $1.69
- DRIO $1.93
- Technical
- Relative Strength Index (RSI)
- RNXT 60.35
- DRIO 56.72
- Support Level
- RNXT $1.02
- DRIO $0.68
- Resistance Level
- RNXT $1.09
- DRIO $0.79
- Average True Range (ATR)
- RNXT 0.05
- DRIO 0.06
- MACD
- RNXT 0.01
- DRIO -0.00
- Stochastic Oscillator
- RNXT 80.00
- DRIO 50.00
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.